Scott Koenig - May 16, 2022 Form 4 Insider Report for MACROGENICS INC (MGNX)

Role
President and CEO, Director
Signature
/s/ Lynn Cilinski, Attorney-in-Fact
Stock symbol
MGNX
Transactions as of
May 16, 2022
Transactions value $
$0
Form type
4
Date filed
5/17/2022, 05:20 PM
Previous filing
Feb 24, 2022
Next filing
May 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MGNX Common Stock Options Exercise $80.4K +53.3K +5.35% $1.51 1.05M May 16, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MGNX Employee stock option (right to buy) Options Exercise -$80.4K -53.3K -100% $1.51 0 May 16, 2022 Common Stock 53.3K $1.51 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction represents an exercise and hold of options. The shares are jointly owned with reporting person's spouse.
F2 12.5% of the shares underlying the grant became exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.